This report is an analysis of the industry drivers and inhibitors within the pharmaceutical industry that will affect the take up of CRM.
Scope of this title:
Pharmaceutical companies are facing a multi-layered assault on their profit margins Lack of ROI to date is holding pharmaceutical companies back from investing in CRM Each region is producing differing challenges for the pharmaceutical industry
Highlights of this title:
The pharmaceutical industry is facing a number of pressures on its profit margins. This report looks at these pressures and analysis how they are affecting the growth in the CRM.
Reasons to order your copy: Learn what the key drivers are for the take up of CRM in the pharmaceutical industry are. Understand the constraints that are holding back investment in CRM solutions. Understand how the differences between each nations characteristics are going to affect the growth in each country.
